Your browser doesn't support javascript.
loading
Holistic management of patients with progressive pulmonary fibrosis.
Oliveira, Ana; Fabbri, Gaia; Gille, Thomas; Bargagli, Elena; Duchemann, Boris; Evans, Rachel; Pinnock, Hilary; Holland, Anne E; Renzoni, Elisabetta; Ekström, Magnus; Jones, Steve; Wijsenbeek, Marlies; Dinh-Xuan, Anh Tuan; Vagheggini, Guido.
Affiliation
  • Oliveira A; Lab 3R Respiratory Research and Rehabilitation Laboratory, School of Health Sciences, University of Aveiro (ESSUA), IBMED Aveiro PT, Aveiro, Portugal.
  • Fabbri G; School of Rehabilitation Science, Faculty of Health Science, McMaster University, Hamilton, ON, Canada.
  • Gille T; Respiratory Diseases and Lung Transplantation Unit, Department of Medical and Surgical Sciences and Neuro-Sciences, University of Siena, Siena, Italy.
  • Bargagli E; Inserm U1272 "Hypoxia & the Lung", UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord, Bobigny, France.
  • Duchemann B; Service Physiologie et Explorations Fonctionnelles, Hôpitaux Universitaires de Paris Seine-Saint-Denis, Assistance Publique - Hôpitaux de Paris, Bobigny, France.
  • Evans R; Respiratory Diseases and Lung Transplantation Unit, Department of Medical and Surgical Sciences and Neuro-Sciences, University of Siena, Siena, Italy.
  • Pinnock H; Inserm U1272 "Hypoxia & the Lung", UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord, Bobigny, France.
  • Holland AE; Service d'oncologie médicale et thoracique, Hôpitaux Universitaires de Paris Seine-Saint-Denis, Assistance Publique - Hôpitaux de Paris, Bobigny, France.
  • Renzoni E; Department of Respiratory Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.
  • Ekström M; Allergy and Respiratory Research Group, Usher Institute, The University of Edinburgh, Edinburgh, UK.
  • Jones S; Central Clinical School, Monash University and Department of Physiotherapy, Alfred Health, Melbourne, Australia.
  • Wijsenbeek M; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Dinh-Xuan AT; Margaret Turner Warwick Centre for Fibrosing Lung Diseases, NHLI, Imperial College, London, UK.
  • Vagheggini G; Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology and Palliative Medicine, Lund, Sweden.
Breathe (Sheff) ; 19(3): 230101, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37719243
ABSTRACT
Progressive pulmonary fibrosis (PF) is a complex interstitial lung disease that impacts substantially on patients' daily lives, requiring personalised and integrated care. We summarise the main needs of patients with PF and their caregivers, and suggest a supportive care approach. Individualised care, education, emotional and psychological support, specialised treatments, and better access to information and resources are necessary. Management should start at diagnosis, be tailored to the patient's needs, and consider end-of-life care. Pharmacological and non-pharmacological interventions should be individualised, including oxygen therapy and pulmonary rehabilitation, with digital healthcare utilised as appropriate. Further research is needed to address technical issues related to oxygen delivery and digital healthcare. Educational

aims:

To identify the main needs of patients with PF and their caregivers.To describe the components of a comprehensive approach to a supportive care programme for patients with PF.To identify further areas of research to address technical issues related to the management of patients with PF.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Breathe (Sheff) Year: 2023 Document type: Article Affiliation country: Portugal

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Breathe (Sheff) Year: 2023 Document type: Article Affiliation country: Portugal
...